| Sharon Marie Somaine, RN | |
|
50 Lawrence Rd, Springfield, NJ 07081-3121 | |
| (908) 931-9111 | |
| Not Available |
| Full Name | Sharon Marie Somaine |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Infusion Therapy |
| Location | 50 Lawrence Rd, Springfield, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649851775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WI0500X | Registered Nurse - Infusion Therapy | 26NO11817500 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharon Marie Somaine, RN 50 Lawrence Rd, Springfield, NJ 07081-3121 Ph: (908) 931-9111 | Sharon Marie Somaine, RN 50 Lawrence Rd, Springfield, NJ 07081-3121 Ph: (908) 931-9111 |
News Archive
UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience C'Nano which was held in Dijon in early December.
"Pfizer Inc., the world's largest drugmaker, and hospital companies including Community Health Systems Inc. are benefiting from agreements with President Barack Obama that will limit any threat to their profits."
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced today the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada.
Sucralose, a widely used artificial sweetener sold under the trade name Splenda®, is metabolized in the gut, producing at least two fat-soluble compounds, according to a recent study using rats.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
› Verified 3 days ago
Linda Sinins, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 36 Troy Dr Apt C, Springfield, NJ 07081 Phone: 973-953-7518 | |
Gaelle Ladouceur, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 Victory Rd Apt 130, Springfield, NJ 07081 Phone: 404-734-2053 | |
Nicholas Gichuki Mwangi, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 195 Mountain Ave, Springfield, NJ 07081 Phone: 973-295-6335 | |
Barbara Marie Baratta, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 76 S Maple Ave, Springfield, NJ 07081 Phone: 718-801-2336 |